Tenax Therapeutics Inc

Tenax Therapeutics names Thomas Staab CFO to strengthen finances for levosimendan‑based PH‑HF‑pEF drug development, boosting investor confidence and capital strategy.

Explore Tenax Therapeutics, a biotech firm targeting pulmonary hypertension and heart failure with levosimendan, its stock trends, and valuation insights.